Skip to main content
NCBI home page
Journal of Anatomy logoLink to Journal of Anatomy
. 1996 Feb;188(Pt 1):157–165.

Expression of tenascin in joint-associated tissues during development and postnatal growth.

E J Mackie 1, S Ramsey 1
PMCID: PMC1167643  PMID: 8655402

Abstract

The extracellular matrix protein, tenascin, is selectively expressed in a variety of connective tissues during development. In this study, the distribution of tenascin in tissues contributing to the knee joint during embryonic development and postnatal growth in the rat has been investigated by immunohistochemistry. In recently formed embryonic knee joints, tenascin expression was abundant in the territorial matrix of superficial articular cartilage. Site of attachment of cruciate and patellar ligaments to cartilage were strongly stained; staining of ligaments weakened with distance from the attachment site. In rapidly growing 4-wk-old rats, tenascin was present in a fine line on the surface of articular cartilage, but at 10 wk of age tenascin staining was absent from most of the articular surface. In postnatal rats, there was strong tenascin staining of the synovial lining, but not of subintimal tissue. Cruciate ligaments were histologically fibrocartilaginous in 4 and 10-wk-old rats; within these ligaments strong pericellular tenascin staining was seen in association with rounded chondrocyte-like cells. Tenascin was absent from the cartilaginous growth plates of 4 and 10-wk-old rats, but intense tenascin staining was seen at the junction between epiphyseal bone and growth plate. Within the metaphysis, tenascin staining on bone surfaces increased with distance from the hypertrophic chondrocytes. Osteocytes within epiphyseal trabecular bone were strongly stained for tenascin, whereas those in the metaphysis were mostly unstained. The results presented here demonstrate that tenascin expression in joint-associated tissues changes markedly with cell type and stage of differentiation.

Full text

PDF
157

Images in this article

160Fig. 1
on p.160
161Fig. 2
on p.161
161Fig. 3
on p.161
162Fig. 4
on p.162
163Fig. 5
on p.163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carter D. H., Sloan P., Aaron J. E. Immunolocalization of collagen types I and III, tenascin, and fibronectin in intramembranous bone. J Histochem Cytochem. 1991 May;39(5):599–606. doi: 10.1177/39.5.1707904. [DOI] [PubMed] [Google Scholar]
  2. Chiquet-Ehrismann R., Kalla P., Pearson C. A., Beck K., Chiquet M. Tenascin interferes with fibronectin action. Cell. 1988 May 6;53(3):383–390. doi: 10.1016/0092-8674(88)90158-4. [DOI] [PubMed] [Google Scholar]
  3. Chiquet M., Fambrough D. M. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol. 1984 Jun;98(6):1926–1936. doi: 10.1083/jcb.98.6.1926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chuong C. M., Widelitz R. B., Jiang T. X., Abbott U. K., Lee Y. S., Chen H. M. Roles of adhesion molecules NCAM and tenascin in limb skeletogenesis: analysis with antibody perturbation, exogenous gene expression, talpid mutants and activin stimulation. Prog Clin Biol Res. 1993;383B:465–474. [PubMed] [Google Scholar]
  5. Cutolo M., Picasso M., Ponassi M., Sun M. Z., Balza E. Tenascin and fibronectin distribution in human normal and pathological synovium. J Rheumatol. 1992 Sep;19(9):1439–1447. [PubMed] [Google Scholar]
  6. Faissner A., Kruse J., Kühn K., Schachner M. Binding of the J1 adhesion molecules to extracellular matrix constituents. J Neurochem. 1990 Mar;54(3):1004–1015. doi: 10.1111/j.1471-4159.1990.tb02350.x. [DOI] [PubMed] [Google Scholar]
  7. Lukinmaa P. L., Mackie E. J., Thesleff I. Immunohistochemical localization of the matrix glycoproteins--tenascin and the ED-sequence-containing form of cellular fibronectin--in human permanent teeth and periodontal ligament. J Dent Res. 1991 Jan;70(1):19–26. doi: 10.1177/00220345910700010201. [DOI] [PubMed] [Google Scholar]
  8. Mackie E. J., Halfter W., Liverani D. Induction of tenascin in healing wounds. J Cell Biol. 1988 Dec;107(6 Pt 2):2757–2767. doi: 10.1083/jcb.107.6.2757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mackie E. J. Tenascin in connective tissue development and pathogenesis. Perspect Dev Neurobiol. 1994;2(1):125–132. [PubMed] [Google Scholar]
  10. Mackie E. J., Thesleff I., Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol. 1987 Dec;105(6 Pt 1):2569–2579. doi: 10.1083/jcb.105.6.2569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mackie E. J., Tucker R. P. Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J Cell Sci. 1992 Nov;103(Pt 3):765–771. doi: 10.1242/jcs.103.3.765. [DOI] [PubMed] [Google Scholar]
  12. McCachren S. S., Lightner V. A. Expression of human tenascin in synovitis and its regulation by interleukin-1. Arthritis Rheum. 1992 Oct;35(10):1185–1196. doi: 10.1002/art.1780351011. [DOI] [PubMed] [Google Scholar]
  13. Nies D. E., Hemesath T. J., Kim J. H., Gulcher J. R., Stefansson K. The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats. J Biol Chem. 1991 Feb 15;266(5):2818–2823. [PubMed] [Google Scholar]
  14. Pacifici M., Iwamoto M., Golden E. B., Leatherman J. L., Lee Y. S., Chuong C. M. Tenascin is associated with articular cartilage development. Dev Dyn. 1993 Oct;198(2):123–134. doi: 10.1002/aja.1001980206. [DOI] [PubMed] [Google Scholar]
  15. Robbins J. R., Vogel K. G. Regional expression of mRNA for proteoglycans and collagen in tendon. Eur J Cell Biol. 1994 Aug;64(2):264–270. [PubMed] [Google Scholar]
  16. Rufai A., Benjamin M., Ralphs J. R. Development and ageing of phenotypically distinct fibrocartilages associated with the rat Achilles tendon. Anat Embryol (Berl) 1992 Dec;186(6):611–618. doi: 10.1007/BF00186984. [DOI] [PubMed] [Google Scholar]
  17. Sage E. H., Bornstein P. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J Biol Chem. 1991 Aug 15;266(23):14831–14834. [PubMed] [Google Scholar]
  18. Salter D. M. Tenascin is increased in cartilage and synovium from arthritic knees. Br J Rheumatol. 1993 Sep;32(9):780–786. doi: 10.1093/rheumatology/32.9.780. [DOI] [PubMed] [Google Scholar]
  19. Spring J., Beck K., Chiquet-Ehrismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell. 1989 Oct 20;59(2):325–334. doi: 10.1016/0092-8674(89)90294-8. [DOI] [PubMed] [Google Scholar]
  20. Thesleff I., Kantomaa T., Mackie E., Chiquet-Ehrismann R. Immunohistochemical localization of the matrix glycoprotein tenascin in the skull of the growing rat. Arch Oral Biol. 1988;33(6):383–390. doi: 10.1016/0003-9969(88)90194-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Anatomy are provided here courtesy of Anatomical Society of Great Britain and Ireland

RESOURCES